𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Percutaneous ethanol instillation therapy for hepatocellular carcinoma – a randomized controlled trial

✍ Scribed by Christian Müller; Maximilian Schöniger-Hekele; Rüdiger Schernthaner; Barbara Renner; Markus Peck-Radosavljevic; Andrea Brichta; Fritz Wrba; Martin Posch; Peter Bauer; Peter Ferenci; Alfred Gangl

Publisher
Springer Vienna
Year
2008
Tongue
English
Weight
358 KB
Volume
120
Category
Article
ISSN
0043-5325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective randomized controlled trial
Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma
✍ Kunihiko Ohnishi; Hisashi Yoshioka; Susumu Ito; Kenji Fujiwara 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

To assess whether ultrasound-guided percutaneous acetic acid injection is superior to percutaneous ethanol injection in the treatment of small hepatocellular carcinoma (HCC), 60 patients with one to four HCCs smaller than 3 cm were entered onto a randomized controlled trial. Thirty-one and 29 patien

Systematic review of randomized trials f
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies
✍ Yun Ku Cho; Jae Kyun Kim; Mi Young Kim; Hyunchul Rhim; Joon Koo Han 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB

According to the American Association for the Study of Liver Diseases guidelines, percutaneous ethanol injection (PEI) is a safe and highly effective treatment for small hepatocellular carcinomas (HCC) and should be the standard against which any new therapy is compared. The primary purpose of this

Randomized controlled trial of interfero
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
✍ Josep M. Llovet; Margarita Sala; Lluís Castells; Yanette Suarez; Ramon Vilana; L 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati